Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
Are Prescription Price Controls in New Jersey’s Future?
Earlier this year in the state of New Jersey, a state senator introduced Senate Bill 977, “Prohibits excessive charges for drugs…
HHS Claims Lower Drug Prices Following “American Patients First” Blueprint
On May 11, 2018, the White House announced its American Patients First Blueprint aimed at reducing drug prices. Following the…
California Court Dismisses PhRMA Transparency Lawsuit
On August 30, 2018, the United States District Court for the Eastern District of California dismissed a lawsuit brought by the…
Prescription Copays More Expensive Than Full Price?
A study published this year by the University of Southern California’s Schaeffer Center for Health Policy and Economics,…
Ohio Cracking Down on PBM Contracts
On Thursday, August 16, 2018, Ohio Auditor of State Dave Yost released findings from June that pharmacy benefit managers (PBMs)…
Senate Passes FY 2019 Funding Bill With Bipartisan Vote – Includes Funds…
On August 23, the Senate passed the fiscal year 2019 Departments of Labor, Health and Human Services, Education funding bill with…
Medicare Part D Premiums Continue to Decline
On July 31, 2018, the United States Centers for Medicare & Medicaid Services announced that for the second year in a row, the…
Mayo Clinic Releases Paper on Cancer Drug Pricing Economic Trade-offs
Recently, the Mayo Clinic published a paper on the importance of economic trade-offs in cancer drug pricing. The paper, written by…
Subcommittee on Health to Hold Hearing on Reforming the 340B Drug Pricing…
The House Energy and Commerce Subcommittee on Health announced they will hold a hearing on Wednesday, July 11, 2018, at 10:00…
Azar Continues to Promote Administration Drug Pricing Policy, Plus RFI…
On June 26, 2018, the Senate Finance Committee held a hearing to examine President Donald Trump’s plan to lower prescription drug…